Can You Have Plastic Surgery in Turkey While Taking Ozempic, Wegovy or Mounjaro?

Many people considering plastic surgery in Turkey also take Ozempic, Wegovy, Mounjaro or another GLP-1-based medicine for diabetes or weight management. These medicines may affect digestion and anesthesia planning, so treatment decisions should be coordinated by the surgical team, anesthesia team and the clinician who prescribed the medicine.

In Short

In many cases, taking Ozempic, Wegovy or Mounjaro does not automatically prevent plastic surgery in Turkey. However, GLP-1 medicines can delay stomach emptying and may affect anesthesia planning, particularly during dose escalation or when significant gastrointestinal symptoms are present. Do not independently stop, continue or restart the medicine; the plan should be confirmed by the prescribing clinician and the surgical and anesthesia teams before travel.

Traveling to Turkey does not remove the usual risks associated with general anesthesia or deep sedation. International patients should share complete medication information with Estexper Clinic well before travelling rather than waiting until the day of surgery.

Can you have plastic surgery in Turkey while taking Ozempic, Wegovy or Mounjaro?

In many cases, patients may be able to undergo plastic surgery while taking a GLP-1 medicine. However, there is no single rule that applies to everyone. The assessment may consider the medicine used, dose, reason for treatment, timing of the last dose, whether the dose is being increased and whether digestive symptoms are present.

Ozempic and Wegovy contain semaglutide. Mounjaro contains tirzepatide, which acts on both GLP-1 and GIP pathways. These medicines can slow gastric emptying, meaning food may remain in the stomach for longer. They may also cause nausea, vomiting and other gastrointestinal symptoms. This is relevant to general anesthesia and deep sedation because stomach contents can potentially enter the lungs, a complication known as pulmonary aspiration.

The prescribing information for Ozempic, Wegovy and Mounjaro warns patients to tell healthcare providers about treatment before planned surgery or procedures. The labels also state that available evidence is insufficient to determine whether temporarily stopping the medicine or changing fasting instructions reduces aspiration risk.

Why do GLP-1 medicines matter before anesthesia?

During general anesthesia or deep sedation, normal protective reflexes can be reduced. If the stomach contains food or liquid, there may be a risk of it moving into the airway. Delayed gastric emptying and gastrointestinal symptoms can therefore influence the anesthesia plan.

This does not mean that every patient taking a GLP-1 medicine has an unacceptably high risk. Current professional guidance is not completely uniform, and recommendations are developing as more evidence becomes available. The October 2024 multisociety guidance generally supports continuing GLP-1 medicines for most patients before elective procedures, provided the team carries out an individualized risk assessment and uses suitable precautions when needed.

Another multidisciplinary consensus statement, published through the Society for Perioperative Assessment and Quality Improvement, also supports continuation in patients without significant gastrointestinal symptoms but discusses more restrictive fasting measures, including fasting from solid food for 24 hours before anesthesia. These differences demonstrate why patients should not make medication decisions independently or rely on general online instructions.

When may the risk be higher?

Your plastic surgeon and anesthesiologist may consider additional precautions or reassessment when one or more of the following applies:

• You are in the dose-escalation phase, when the dose is being increased.
• You are taking a higher dose.
• You have significant nausea, vomiting, bloating or difficulty tolerating food.
• You cannot maintain normal oral intake.
• You have a condition associated with delayed gastric emptying or other significant gastrointestinal disease.

Active vomiting, significant nausea or an inability to tolerate food should be reported promptly. Depending on the circumstances, the anesthesia team may recommend further medical review, additional precautions, a change to the anesthesia plan or postponement of elective surgery until the situation is safer.

Should you stop Ozempic, Wegovy or Mounjaro before surgery?

Do not stop or change your medicine solely because you are having surgery abroad. The appropriate approach depends on your individual medical situation and the protocol used by the treating team. Stopping treatment may affect blood sugar control and may also affect weight-management treatment.

At the same time, continuing treatment should not be assumed to be appropriate without assessment. The prescribing clinician, plastic surgeon and anesthesiologist should consider the benefits and risks of continuation, any symptoms you have, the timing of your last dose and the planned type of anesthesia.

Ask Estexper Clinic to confirm its current perioperative protocol before booking travel. You should also ask your prescribing clinician for advice in advance, particularly if you use the medicine for diabetes. Any plan for pausing or restarting treatment should be documented and communicated to everyone involved in your care.

What information should you provide before travelling to Turkey?

International patients should send accurate medical information to the clinic during the consultation process. This allows the surgical and anesthesia teams to assess the situation before travel arrangements are made.

Provide the following details:

• The exact name of the medicine, such as semaglutide or tirzepatide.
• The brand name, such as Ozempic, Wegovy or Mounjaro.
• Your current dose and how often you take it.
• The date and time of your most recent dose.
• Why the medicine was prescribed, such as diabetes or weight management.
• Whether your dose is currently being increased.
• Any nausea, vomiting, reflux, bloating, abdominal symptoms or difficulty eating.
• Other medicines, allergies and relevant medical conditions.
• Advice already provided by your prescribing clinician.

A medication list, prescription information and relevant medical records can help avoid misunderstandings. Do not assume that a brand name alone provides enough information, especially if your medicine was prescribed outside Turkey.

How should you prepare for plastic surgery in Turkey?

Arrange an early medical review

Discuss your planned procedure with the clinician who prescribes your GLP-1 medicine. Tell them the proposed surgery date, the likely type of anesthesia and whether you will be travelling internationally. Estexper Clinic should also receive this information well before arrival.

Confirm the anesthesia plan

Ask whether your procedure is expected to involve local anesthesia, sedation or general anesthesia. Aspiration concerns are particularly relevant to general anesthesia and deep sedation, although the anesthesia team will determine which precautions are appropriate for your circumstances.

Report gastrointestinal symptoms honestly

Do not minimize nausea or vomiting because you are worried that surgery may be delayed. These symptoms can affect the safety assessment. If they occur after your preoperative review or during travel, contact the clinic before attending the procedure.

Follow the clinic’s fasting instructions

Fasting instructions may be individualized. Some professional recommendations support continuation of GLP-1 medicines for many patients with appropriate precautions, while other consensus guidance discusses a 24-hour fast from solid food. Follow the specific instructions given by your anesthesiologist rather than combining advice from different sources.

Can surgery be postponed?

Yes. If the medical team believes that the risk is not acceptable at that time, an elective procedure may need to be modified or postponed. This may be considered when significant gastrointestinal symptoms are active, when you are unable to tolerate food, during dose escalation or when another condition may delay gastric emptying.

Postponement is not necessarily a sign that surgery cannot be considered in the future. It may allow time for symptoms to settle, for the prescribing clinician to review treatment or for the team to create a safer anesthesia plan. Timing should be decided by qualified clinicians who understand both the medical history and the planned operation.

What happens on the day of surgery?

Before anesthesia, tell the healthcare team again that you use a GLP-1 or GLP-1/GIP medicine. Confirm the name, dose and timing of your last dose. The anesthesiologist may ask about recent food and fluid intake, nausea, vomiting and other digestive symptoms.

The team may use risk-reduction measures based on the assessment. These can include dietary or fasting instructions, changes to the anesthesia plan or, in selected cases, delaying the procedure. The exact approach depends on symptoms, medical history, medication schedule and the operation being performed.

Plastic surgery also involves broader perioperative considerations. The surgical team may discuss nutritional status, diabetes management, wound-healing considerations and how the medicine will be managed after the operation. These issues may be important if reduced appetite or weight loss has affected adequate nutrition.

What about restarting the medicine after surgery?

Do not restart a paused medicine without confirming the plan with your prescribing clinician and surgical team. The appropriate timing may depend on recovery, ability to eat and drink, blood sugar control, gastrointestinal symptoms and any complications.

Before leaving Turkey, ask who will manage your medication after the procedure and how communication will take place once you return home. Discharge instructions should clearly state whether treatment was continued, paused or changed, and what follow-up is required. If you develop persistent vomiting, difficulty keeping fluids down or other concerning symptoms after surgery, seek medical advice promptly.

Does having surgery in Turkey change the risks?

The destination country does not eliminate the underlying effects of GLP-1 medicines or the risks associated with anesthesia. Surgery in Turkey may be considered when the patient is appropriately assessed and the clinic, anesthesiologist and prescribing clinician communicate effectively.

International travel creates additional practical responsibilities. Allow enough time for preoperative assessment, provide complete records, understand the clinic’s medication policy and avoid making last-minute medication changes without medical advice. Arrange follow-up before returning home and ensure that your usual healthcare provider knows about the procedure and any medication changes.

Frequently asked questions

Can I have plastic surgery if I take Wegovy for weight loss?

Possibly. Wegovy does not automatically prevent plastic surgery, but the team must assess the dose, symptoms, timing of treatment and anesthesia requirements. Significant nausea, vomiting or difficulty eating may lead to postponement.

Is Mounjaro treated the same way as Ozempic?

They are different medicines, but both can affect gastric emptying and require disclosure before anesthesia. Mounjaro contains tirzepatide, while Ozempic contains semaglutide. The anesthesiologist will make an individualized assessment.

Can I decide to skip my next injection?

No. Medication interruption should not be decided solely by the patient. Stopping treatment can affect glycemic control, and the evidence is insufficient to prove that withholding the medicine eliminates aspiration risk. Discuss any change with your prescribing clinician and the surgical team.

What if I feel sick before flying to Turkey?

Contact Estexper Clinic and your prescribing clinician before travelling if you have significant nausea, vomiting or difficulty tolerating food. The procedure may need reassessment, and symptoms should not be concealed to avoid a possible delay.

Key takeaways

• Many patients taking Ozempic, Wegovy, Mounjaro or another GLP-1 medicine may still be suitable for plastic surgery in Turkey.
• These medicines should be disclosed to the plastic surgeon, anesthesiologist and prescribing clinician well before surgery.
• Risk may be higher during dose escalation or when significant gastrointestinal symptoms are present.
• Do not stop, continue or restart treatment without an individualized medical plan.
• Follow the clinic’s fasting and anesthesia instructions, which may differ according to your risk assessment.
• Ask for clear postoperative medication and follow-up instructions before returning home.

At Estexper Clinic, patients should provide complete medication and medical information during consultation so the surgical and anesthesia teams can plan appropriately. Final suitability for surgery must be determined by qualified physicians after reviewing the individual’s health, treatment and procedure.

Medical References

1. Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period, American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, American Society of Anesthesiologists, International Society of Perioperative Care of Patients with Obesity, and Society of American Gastrointestinal and Endoscopic Surgeons. Read the guidance.
2. Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement multidisciplinary consensus statement, Society for Perioperative Assessment and Quality Improvement; British Journal of Anaesthesia. View the consensus statement.
3. WEGOVY prescribing information, 2026, U.S. Food and Drug Administration. View prescribing information.
4. MOUNJARO prescribing information, 2026, U.S. Food and Drug Administration. View prescribing information.
5. Injectable Weight Loss Medications in Plastic Surgery: What We Know, Perioperative Considerations, and Recommendations for the Future, American Society of Plastic Surgeons; Plastic and Reconstructive Surgery. View the publication.